Literature DB >> 1652143

Role of central versus peripheral opioid receptors in analgesia induced by repeated administration of opioid antagonists.

M J Walker1, A D Lê, C X Poulos, H Cappell.   

Abstract

Although analgesia induced by blockade of opioid receptors has been well established, it is still unknown whether its development is mediated by the blockade of centrally located opioid receptors. Therefore, rats were treated with either systemically or ICV applied naloxone or quaternary naltrexone (QN), an opioid antagonist that does not easily penetrate the blood-brain barrier. Following antagonist administration, each animal was tested for paw lick latency on a 51 degrees C hot plate. Hot plate testing and drug injections were carried out for 4 consecutive days. Rats treated with ICV microinjections of QN or naloxone displayed paw lick latencies that were significantly longer than those observed in control animals. In contrast, rats treated with SC injections of QN did not show any increase in paw lick latency, whereas rats treated with SC injections of naloxone displayed paw lick latencies that were significantly longer than those of control rats. These results are consistent with the hypothesis that the blockade of central opioid receptors underlies the development of an analgesic response.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652143     DOI: 10.1007/bf02244172

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

1.  Enhancement of naloxone-induced analgesia by pretreatment with morphine.

Authors:  H Cappell; C X Poulos; A D Lê
Journal:  Pharmacol Biochem Behav       Date:  1989-10       Impact factor: 3.533

2.  Activation and expression of endogenous pain control mechanisms in rats given repeated nociceptive tests under the influence of naloxone.

Authors:  J Rochford; J Stewart
Journal:  Behav Neurosci       Date:  1987-02       Impact factor: 1.912

Review 3.  Hyperalgesic functions of peripheral opiate receptors.

Authors:  D van der Kooy
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

4.  Hyperalgesia mediated by peripheral opiate receptors in the rat.

Authors:  D van der Kooy; J I Nagy
Journal:  Behav Brain Res       Date:  1985-10       Impact factor: 3.332

5.  Some effects of exposure to a heat stressor upon the rat's subsequent reactions to that stressor.

Authors:  J D Greeley; R F Westbrook
Journal:  Q J Exp Psychol B       Date:  1990-08

6.  Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.

Authors:  C Stein; M J Millan; T S Shippenberg; K Peter; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1989-03       Impact factor: 4.030

7.  "Paradoxical" analgesia and aggravated morphine dependence induced by opioid antagonists.

Authors:  T Suzuki; Y Fukagawa; M Misawa; H Nagase
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

8.  Naloxone-induced analgesia: effects of the benzodiazepine antagonist Ro 15-1788.

Authors:  H Cappell; D M Knoke; A D Lê; C X Poulos
Journal:  Pharmacol Biochem Behav       Date:  1989-09       Impact factor: 3.533

9.  Chronic selective blockade of mu opioid receptors produces analgesia and augmentation of the effects of a kappa agonist.

Authors:  M J Walker; A D Lê; C X Poulos; H Cappell
Journal:  Brain Res       Date:  1991-01-11       Impact factor: 3.252

10.  Naloxone-induced analgesia and morphine supersensitivity effects are contingent upon prior exposure to analgesic testing.

Authors:  C X Poulos; D M Knoke; A D Le; H Cappell
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

  10 in total
  4 in total

Review 1.  Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.

Authors:  Antonio Gatti; Alessandro Fabrizio Sabato
Journal:  Clin Drug Investig       Date:  2012-05-01       Impact factor: 2.859

Review 2.  Methylnaltrexone.

Authors:  Karly P Garnock-Jones; Kate McKeage
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

3.  Effects of acute selective 5-HT1, 5-HT2, 5-HT3 receptor and alpha 2 adrenoceptor blockade on naloxone-induced antinociception.

Authors:  M J Walker; C X Poulos; A D Le
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

4.  Methylnaltrexone in the treatment of opioid-induced constipation.

Authors:  Beverley Greenwood-Van Meerveld; Kelly M Standifer
Journal:  Clin Exp Gastroenterol       Date:  2008-12-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.